| PERIOD ENDING | 1-Aug-09 | 2-May-09 | 31-Jan-09 | 1-Nov-08 | | Total Revenue | 341,737 | 333,566 | 455,821 | 333,756 | | Cost of Revenue | 241,540 | 249,083 | 323,113 | 259,036 | | | Gross Profit | 100,197 | 84,483 | 132,708 | 74,720 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 83,854 | 83,606 | 89,969 | 84,417 | | Non Recurring | 465 | 1,186 | 600 | 97,714 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,878 | (309) | 42,139 | (107,411) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 76 |
-
| 12 |
-
| | Earnings Before Interest And Taxes | 15,954 | (309) | 42,151 | (107,411) | | Interest Expense | 1,217 | 1,158 | 1,341 | 1,365 | | Income Before Tax | 14,737 | (1,467) | 40,810 | (108,776) | | Income Tax Expense | 5,644 | (562) | 15,475 | (5,980) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,093 | (905) | 25,335 | (102,796) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,093 | (905) | 25,335 | (102,796) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,093 | ($905) | $25,335 | ($102,796) |
|
0.29% Nasdaq 
0.34 (2.58%) 
Income Statement
